Candela Announces Launch of the Glacē™ Treatment at American Academy of Dermatology (AAD) Annual Meeting

Advanced Hydrodermabrasion Solution Addresses Global Demand for 'Glass Skin' Facial

MARLBOROUGH, Mass., March 7, 2025 /PRNewswire/ -- Candela Corporation (Candela), a leading global medical aesthetic device company headquartered in Marlborough, MA, today announced the global launch of the Glacē solution (pronounced ˈGLASS-ee / 'GLASS-ie / 'GLASS-y) at the 2025 American Academy of Dermatology (AAD) Annual Meeting. Inspired by the K-beauty trend for 'glass skin' – a smooth, poreless, and radiant complexion - the Glacē treatment combines hydrodermabrasion, dual-mode cupping massage, and LED technology to deliver advanced skin purification and hydration.

Glacē is the only skin purification treatment to incorporate dual-mode cupping massage, offering two modes – one to support lymphatic drainage and natural detoxification, and another that provides a temporarily sculpted look. Its customizable two-phase serum system delivers tailored treatments for various skin types and concerns, including acne, sensitivity, dryness, uneven tone, and signs of aging. Treatment can be performed as a standalone procedure or integrated with energy-based devices (EBDs), helping medical aesthetics practices enhance treatment outcomes and maximize their revenue potential.

"Candela has long been a leader in innovating energy-based devices for dermatology. With the growing demand for natural and non-invasive treatments, the launch of the Glacē treatment marks an exciting milestone for Candela. As our first solution to integrate a broad range of cosmeceuticals for comprehensive skin health, Glacē treatments can be delivered stand alone or in combination with our advanced energy-based technologies using Candela developed protocols. Glacē underscores our commitment to delivering cutting-edge solutions for a wider range of medical aesthetic practices," said Geoff Crouse, CEO of Candela.

Backed by clinical studies, the Glacē treatment demonstrates impressive outcomes with:

• 100% of subjects reporting visibly cleaner skin,
• 97% experiencing improved hydration, and
• 92% choosing to return for future treatments.

For practitioners, the treatment has proven to be a significant enhancement to workflow. "The Glacē treatment has been a valuable addition to my practice," said Dr. Konika Schallen, Senior Vice President of Global Clinical Operations and Medical Director of Candela and the Candela Institute of Excellence (CIE). "Its full-body versatility, generous serums, and dual-mode cupping capabilities have streamlined our workflow. Patients leave with glowing, rejuvenated skin, and the customizable solution allows us to tailor EBD treatments to a wide range of specific patient needs - across various ages, skin types, and tones, including those with darker skin. This makes it an excellent option not only for patients looking for ongoing skin maintenance and anti-aging benefits but also for younger, millennial patients and first-time energy-based device users seeking an effective, approachable entry point into advanced aesthetic treatments."

The Glacē treatment will make its global debut at the AAD Annual Meeting in Orlando, Florida, from March 7-9, 2025. It is now commercially available for sale in the U.S., Europe, Africa, and the Middle East, with availability expanding across Asia Pacific beginning later this month.

For more information about the Glacē Skin Purifying Treatment, visit www.candelamedical.com.

About Candela Corporation
Candela is a leading global medical aesthetic device company with an extensive product portfolio and a global distribution footprint. The company's technology enables physicians to provide advanced solutions for a broad range of medical aesthetic applications including hair removal, skin tightening, renewal and purification, wrinkle reduction, tattoo removal, facial resurfacing, traumatic and surgical scar treatments, benign vascular and pigmented lesions, acne and leg veins. Candela's trusted platforms include Matrix™, Vbeam^®, the Gentle^® Family, Nordlys^® Family, PicoWay^®, and Glacē™. Acquired by Apax Partners in July 2017, Candela markets, services and supports its products in 86 countries worldwide. It has offices in the United States, Australia, Canada, China, France, Germany, Hong Kong, Israel, Italy, Japan, Portugal, Spain, the United Kingdom, as well as many international distributors. 

SOURCE CANDELA